CYTK compared with DNLI: revenue, margins and what each company keeps, and the suppliers and customers both name

CYTKCytokinetics Inc

Mkt capRevenueRevenue

DNLIDenali Therapeutics Inc.

Mkt capRevenueRevenue

Compare

CYTKCytokinetics Inc

DNLIDenali Therapeutics Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Co-movers

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Co-movers

daily closes · 500dMethod ›

Moved together

CYTKwithDNLI

×0.41co-movement · DNLI on CYTK · 500d

r 0.38scale to r 0.75

Shared co-movers2with CYTKwith DNLI

ARWRArrowhead Pharmaceuticals, Inc.r 0.38r 0.48

BEAMBeam Therapeutics Inc.r 0.35r 0.53

CYTK, solidDNLI, hatched× = co-movement · βr = correlationBar = r to r 0.75Order: weaker of A and BSource: daily closes

CYTKCytokinetics Inc

62.06▼−1.48%· post 62.06· delayed

Mkt cap$8.8BRevenue$29MQ2 FY26Revenue$88MFY25

DNLIDenali Therapeutics Inc.

18.87▼−0.37%· post 18.87· delayed

After hoursNov 2 '26delayed

Mkt cap$3.0BRevenue$4MQ2 FY26Revenue—

Compare

After hoursNov 2 '26delayed

CYTKCytokinetics Inc

DNLIDenali Therapeutics Inc.

62.06▼−1.48%post 62.06delayed

Price

18.87▼−0.37%post 18.87delayed

$8.8B

Mkt cap

$3.0B

Q2 FY26$29M

Revenue

$4MQ2 FY26

FY25$88M

Revenue

—

CYTK62.06▼−1.48%vsDNLI18.87▼−0.37%After hoursNov 2 '26delayed